Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | USP2 | O75604 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | GLA | P06280 | 1/20 | 0.33 |
| ▸ | CTSB | P07858 | 1/20 | 0.31 |
| ▸ | DHFR | P00374 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.31 |
| ▸ | AR | P10275 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | HSPA5 | P11021 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29703193 | 1.00 | KDM4E (0.38) | KDM4ELMNATDP1USP2ALDH1A1 | |
| Glycerin SCHEMBL9580735 | 0.88 | KDM4E (0.33) | KDM4ELMNA | |
| SCHEMBL6436617 | 0.87 | KDM4E (0.38) | KDM4ELMNATDP1USP2ALDH1A1 | |
| SCHEMBL31544651 | 0.87 | KDM4E (0.38) | KDM4ELMNATDP1USP2ALDH1A1 | |
| SCHEMBL30015922 | 0.86 | LMNA (0.43) | KDM4ELMNATDP1USP2ALDH1A1 | |
| SCHEMBL6230504 | 0.86 | LMNA (0.43) | KDM4ELMNATDP1USP2ALDH1A1 | |
| SCHEMBL11115495 | 0.86 | CTSB (0.42) | KDM4ELMNATDP1USP2ALDH1A1 | |
| SCHEMBL10413043 | 0.86 | KDM4E (0.37) | KDM4ELMNATDP1USP2ALDH1A1 | |
| SCHEMBL21717710 | 0.85 | KDM4E (0.32) | KDM4ELMNATDP1ALDH1A1GLA | |
| SCHEMBL11653549 | 0.85 | KDM4E (0.34) | KDM4ELMNAUSP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 313 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11772357-B2 | Surface veil and surface film integrated prepreg layer and processes for making the same | KORDSA TEKNIK TEKSTIL A.S. (TR) | 2023-10-03 | — | — | US | claimed |
| EP-3593808-B1 | PROTON-BINDING POLYMERS FOR ORAL ADMINISTRATION | TRICIDA INC (US) | 2020-12-09 | — | — | EP | claimed |
| US-20200339773-A1 | SURFACE VEIL AND SURFACE FILM INTEGRATED PREPREG LAYER AND PROCESSES FOR MAKING THE SAME | KORDSA TEKNIK TEKSTIL A.S. (TR) | 2020-10-29 | — | — | US | claimed |
| EP-3578185-B1 | PROTON-BINDING POLYMERS FOR ORAL ADMINISTRATION | TRICIDA INC (US) | 2020-08-05 | — | — | EP | claimed |
| EP-3335785-B1 | SELF-HEALING MICROCAPSULES, PROCESS FOR THE PREPARTION THEREOF, POLYMERIC MATRIX AND COMPOSITE MATERIALS COMPRISING THE SAME | FUNDACION TECNALIA RES & INNOVATION (ES) | 2020-03-25 | — | — | EP | claimed |
| EP-3452057-A1 | COMPOSITIONS FOR TREATING ACID-BASE DISORDERS | Tricida Inc. (US) | 2019-03-13 | — | — | EP | claimed |
| WO-2019013716-A1 | PRODUCTION METHOD FOR A COMPOSITE MATERIAL MADE OF RESIN FORMULATION-IMPREGNATED FIBER-REINFORCED INTERMEDIATE | KORDSA TEKNİK TEKSTİL ANONİM ŞİRKETİ (TR) | 2019-01-17 | — | — | WO | claimed |
| EP-3287133-A1 | PROTON-BINDING POLYMERS FOR ORAL ADMINISTRATION | Tricida Inc. (US) | 2018-02-28 | — | — | EP | claimed |
| WO-2017193050-A1 | COMPOSITIONS FOR TREATING ACID-BASE DISORDERS | TRICIDA, INC. (US) | 2017-11-09 | — | — | WO | claimed |
| EP-2172518-B9 | Process for preparing a self-healing composite material | LEONARDO SPA (IT) | 2017-01-25 | — | — | EP | claimed |
| US-20070298006-A1 | Dendritic Polymers With Enhanced Amplification and Interior Functionality | DENDRITIC NANOTECHNOLOGIES, INC. (US) | 2007-12-27 | — | — | US | claimed |
| WO-2007130463-A2 | AMINE CONDENSATION POLYMERS AS PHOSPHATE SEQUESTRANTS | GENZYME CORPORATION (US) | 2007-11-15 | — | — | WO | claimed |
| US-20070244296-A1 | Dendritic Polymers with Enhanced Amplification and Interior Functionality | DENDRITIC NANOTECHNOLOGIES, INC. (US) | 2007-10-18 | — | — | US | claimed |
| WO-2007009797-A1 | AMPHIPHILIC POLYMER COMPOUNDS, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE | CONSTRUCTION RESEARCH & TECHNOLOGY GMBH (DE) | 2007-01-25 | — | — | WO | claimed |
| US-20010020071-A1 | Thermosetting resins | CAPOTE MIGUEL ALBERT (US) | 2001-09-06 | — | — | US | claimed |
| EP-0342027-B1 | Epoxy-aromatic polysiloxane compositions | NAT STARCH CHEM INVEST (US) | 1996-01-24 | — | — | EP | claimed |
| EP-0217657-B1 | Low-viscosity epoxy resin, resin composition containing it, and fibre-reinforced composite material containing cured product of the composition | SUMITOMO CHEMICAL CO (JP) | 1994-04-13 | — | — | EP | claimed |
| EP-0392348-A2 | Toughened thermosetting structural materials | CYTEC TECHNOLOGY CORP. (US) | 1990-10-17 | — | — | EP | claimed |
| US-4957995-A | Low-viscosity epoxy resin, and fiber-reinforced composite material based on m-alkyl triglycidylaminophenols | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1990-09-18 | — | — | US | claimed |
| EP-0148534-B1 | BISMALEIMIDES AND PREPREG RESINS THEREFROM | AMOCO CORPORATION (US) | 1989-03-15 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070298006-A1 | Dendritic Polymers With Enhanced Amplification and Interior Functionality | MYD88, TLR3, TMEM97 | KDM4E 3988/4885LMNA 1465/4885TDP1 3059/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.